BioCentury
ARTICLE | Company News

GenVec, Washington University deal

January 20, 2017 7:33 PM UTC

GenVec said it received an exclusive option from the university for IP and technology related to gene editing and pulmonary endothelial cell targeting technology. GenVec said it will initially combine...